LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Nasal myiasis

    Reyes-Romero, Karen Eliana / Méndez-Fandiño, Yardany Rafael / Rojas-Madero, Fredy Alexánder / Chow-Maya, Diego Ignacio

    Iatreia, Vol 29, Iss 3, Pp 359-

    report of a case and literature review

    2016  Volume 366

    Abstract: Myiasis is the infection of animal or human tissues or organs by larvae of Diptera. It may affect individuals of any age, but is more common in middle-aged and elderly patients. Nasal myiasis, an infection of the nasal and paranasal cavities by such ... ...

    Abstract Myiasis is the infection of animal or human tissues or organs by larvae of Diptera. It may affect individuals of any age, but is more common in middle-aged and elderly patients. Nasal myiasis, an infection of the nasal and paranasal cavities by such larvae, is a common disease in tropical and developing countries. Reported cases of nasal myiasis have been caused by several different species, such as Lucilia sericata in Korea and Iran, Estro ovis in Algeria and France, Lucilia cuprina and Phaenicia sericata in Malaysia, Cochliomyia hominivorax in French Guiana, Drosophila melanogaster in Turkey, Eristalis tenax in Iran and Oestrus ovis in Israel. Signs and symptoms are related to the presence and movement of the larvae, and include foreign body sensation, bloody or muco-purulent nasal discharge. Prevention may be done with insect repellent. Treatment is based on antiparasitic drugs and techniques for removal of larvae, but may include the use of prophylactic topical or systemic antibiotics for possible secondary infections. We report a case of nasal and left maxillary sinus myiasis in an elderly woman, who responded favorably to treatment.
    Keywords Colombia ; Diabetes Mellitus ; Diptera ; Ivermectin ; Myiasis ; Nasal Cavity ; Medicine ; R ; Medicine (General) ; R5-920
    Language Spanish
    Publishing date 2016-07-01T00:00:00Z
    Publisher Universidad de Antioquia
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Article ; Online: COVID-19 pandemic and kidney disease

    Caicedo Mesa, Alberto / Méndez Fandiño, Yardany Rafael / Larrotta Salamanca, Lady Ximena / Díaz Lache, Laura Lorena / Forero Alvarado, María José / Cortés Motta, Héctor Fabio / Acosta Costilla, Álvaro Fernando

    Revista Colombiana de Nefrología; Vol. 7 No. Supl.; Revista Colombiana de Nefrología; Vol. 7 Núm. Supl.2 (2020): Suplemento especial - Pandemia de COVID-19 y Enfermedad Renal - Julio - Diciembre 2020 ; 2500-5006 ; 2389-7708 ; 10.22265/acnef.7.Supl 2

    ¿What do we currently know? ; Pandemia de COVID-19 y enfermedad renal: ¿Qué sabemos actualmente?

    2020  Volume 2, Issue : Suplemento especial - Pandemia de COVID-19 y Enfermedad Renal - Julio - Diciembre 2020

    Abstract: Introduction: Acute kidney disease is relatively frequent in COVID-19 patients, especially in critically ill patients; chronic kidney disease patients are consider as a risk group during COVID-19 pandemic because of immunosuppression associated with ... ...

    Abstract Introduction: Acute kidney disease is relatively frequent in COVID-19 patients, especially in critically ill patients; chronic kidney disease patients are consider as a risk group during COVID-19 pandemic because of immunosuppression associated with their condition, that´s why it is important to detect SARS CoV-2 in this group of patients as in dialysis patients and kidney transplant patients. It is important to identify kidney disease at admission of COVID-19 patients because it has been shown that AKI or kidney disease represent an indicator to value survival and prognosis; literature have established that acute kidney injury is related with worst prognosis and mortality. Because of positive impact in survival that means timely and early treatment and follow up of kidney disease in COVID-19 patients. Objective: To presents actual scientific information about acute kidney injury physiopathology in COVID-19 patients, diagnosis, treatment, follow up strategies during hospitalization, management of dialysis units, intravenous liquids indications and shock management in patients with kidney disease. Methods: A literature review was performed using PubMed, Google Scholar and Embase databases; the selection criteria include articles that record the general and specific approach to complications in the context of kidney disease, no filters are used in the search. Conclusion: Renal failure in the context of COVID-19 infection represents an important aspect to study during development of COVID-19 infection and requires special considerations for its correct management.

    Introducción: La enfermedad renal aguda es una patología relativamente frecuente en pacientes con infección por COVID-19, en especial en el grupo de pacientes que se encuentran críticamente enfermos; los pacientes con enfermedad renal crónica se consideran un grupo de riesgo durante la pandemia debido a la inmunosupresión asociada por lo cual es importante la detección de infección por SARS CoV-2 en estos pacientes además de quienes están en diálisis y pacientes con trasplante renal. Es de suma importancia la identificación de enfermedad renal al ingreso de pacientes con COVID-19 pues se ha demostrado que representa un indicador para valorar supervivencia y pronóstico; varios estudios han establecido que la falla renal aguda se relaciona directamente con peor pronóstico y mortalidad. Debido al impacto positivo en la supervivencia que significa el manejo oportuno de la falla renal en pacientes positivos para COVID-19. Objetivo: Presentar la información científica actual sobre la fisiopatología de falla renal en contexto de COVID-19, diagnóstico, tratamiento, estrategias de seguimiento de la función renal durante la hospitalización, manejo de unidades de diálisis, indicación de líquidos intravenosos y manejo de shock en pacientes con enfermedad renal. Métodos: Se realizó una revisión de la literatura utilizando las bases de datos PubMed, Google Scholar y Embase; los criterios de selección incluían artículos que registraran el abordaje general y específico de complicaciones en el contexto de enfermedad renal, no se usaron filtros en la búsqueda. Conclusión: La falla renal en el contexto de la infección por COVID-19 representa un aspecto importante a estudiar dentro del desarrollo de la enfermedad y requiere consideraciones especiales para su manejo.
    Keywords acute kidney injury ; COVID-19 ; kidney diseases ; ACE2 ; novel coronavirus 2019 ; dialysis ; chronic kidney disease ; lesión renal aguda ; 2019-nCoV ; enfermedades renales ; enzima convertidora de angiotensina ; nuevo coronavirus 2019 ; diálisis renal ; fallo renal crónico ; covid19
    Language Spanish
    Publishing date 2020-05-08
    Publisher Asociación Colombiana de Nefrologia e Hipertension Arterial
    Publishing country co
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  3. Article ; Online: Treatment of bacteremia by vancomycin-resistant Enterococcus with daptomycin versus linezolid

    Caicedo-Ochoa, Edgar Yaset / Urrutia-Gómez, Jorge Andrés / Fernández-Niño, Daniel Sebastián / Guío-Guerra, Santiago Alejandro / Méndez-Fandiño, Yardany Rafael

    Iatreia, Vol 30, Iss 1, Pp 5-

    a systematic review and meta-analyses

    2017  Volume 20

    Abstract: Introduction: Second-line drugs such as linezolid and daptomycin are used for treatment of vancomycin-resistant Enterococcus (VRE) infections. Objective: A systematic review to evaluate treatment of VRE bacteremia with linezolid versus daptomycin. ... ...

    Abstract Introduction: Second-line drugs such as linezolid and daptomycin are used for treatment of vancomycin-resistant Enterococcus (VRE) infections. Objective: A systematic review to evaluate treatment of VRE bacteremia with linezolid versus daptomycin. Methods: A search was done in the databases of Pubmed, Embase, Scopus, ScienceDirect, CENTRAL, Lilacs and Google Scholar to identify studies comparing treatment with daptomycin or linezolid of patients infected by VRE up to July 2015. Result: Only 15 studies were included of a total of 1.307 records. There were no differences between daptomycin and linezolid with respect to mortality at 30 days. Microbiological cure was better with daptomycin (OR: 0.64; 95 % CI: 0.45-0.92), whereas there was no difference between the two antibiotics with respect to clinical cure, need to ICU admission, and the occurrence of adverse effects such as thrombocytopenia, neutropenia and renal failure. Conclusions: No significant differences were observed between daptomycin and linezolid in reference to mortality of patients infected with VRE, although daptomycin treatment produced a faster microbiological cure.
    Keywords Antimicrobial resistance ; Daptomycin ; Enterococcus ; Linezolid ; Mortality ; Medicine ; R ; Medicine (General) ; R5-920
    Language Spanish
    Publishing date 2017-01-01T00:00:00Z
    Publisher Universidad de Antioquia
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  4. Article ; Online: Assessment of the use of vitamin C and E supplements concomitantly to antibiotic treatment against Helicobacter pylori: A systematic review and meta-analysis.

    Caicedo Ochoa, Edgar Yaset / Quintero Moreno, César Orlando / Méndez Fandiño, Yardany Rafael / Sánchez Fonseca, Sofía Catalina / Cortes Motta, Héctor Fabio / Guio Guerra, Santiago Alejandro

    Medicina clinica

    2017  Volume 151, Issue 2, Page(s) 45–52

    Abstract: Introduction: Helicobacter pylori infections affect almost 50% of the world population, constituting a risk factor for benign and malignant gastrointestinal diseases. The increased resistance to antibiotic treatment against this infection represents a ... ...

    Title translation Evaluación del suplemento de vitaminas C y E en el tratamiento antibiótico contra Helicobacter pylori: revisión sistemática y metaanálisis.
    Abstract Introduction: Helicobacter pylori infections affect almost 50% of the world population, constituting a risk factor for benign and malignant gastrointestinal diseases. The increased resistance to antibiotic treatment against this infection represents a dilemma in the search of other therapeutic alternatives.
    Objective: To determine the efficacy of the use of vitaminC and E supplements concomitantly to antibiotic treatment against H. pylori infections.
    Methods: We performed a systematic review on the MedLine (PubMed), Embase and Cochrane Central Register of Clinical Trials (CENTRAL) databases, searching for studies evaluating the efficacy of vitaminC and/or E supplements in the antibiotic treatment of H. pylori infections. The primary outcome was eradication of the infection. The secondary outcome was the adverse effects. The meta-analysis was conducted using the random effects method.
    Results: Ten studies were included and analyzed in two groups. The first group, which was comprised by 973patients, compared the use of supplementation with vitaminC and E, showing that, without discriminating the number of antibiotics used, there was no relationship with the eradication of the infection (OR: 1.98 [95%CI: 0.92-4.29] P=.08). The triple or quadruple antibiotic therapy had no effect on eradication rates either (OR 1.80 [95%CI: 0.64-5.08] P=.26 and OR: 2.84 [95%CI: 0.51-15.56] P=.22, respectively). No effect on the eradication rates was observed either in the group that only assessed the use of vitaminC, comprised by 702patients (OR: 1.17 [95%CI: 0.58-2.31] P=.65). Only four studies reported adverse effects, the most common one being nausea.
    Conclusions: Supplementation with vitaminC and E in the antibiotic treatment against H. pylori has no effect. However, the reviewed studies had several biases and differences in the dosage of the supplements and antibiotics administered.
    MeSH term(s) Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/therapeutic use ; Ascorbic Acid/administration & dosage ; Ascorbic Acid/adverse effects ; Drug Therapy, Combination ; Helicobacter Infections/drug therapy ; Helicobacter pylori ; Humans ; Odds Ratio ; Vitamin E/administration & dosage ; Vitamin E/adverse effects ; Vitamins/administration & dosage ; Vitamins/adverse effects
    Chemical Substances Anti-Bacterial Agents ; Vitamins ; Vitamin E (1406-18-4) ; Ascorbic Acid (PQ6CK8PD0R)
    Language Spanish
    Publishing date 2017-11-02
    Publishing country Spain
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2017.09.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.279: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top